BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6109019)

  • 1. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
    Wiech NL; Martin JS
    Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain.
    Yeramian E; Garbarg M; Schwartz JC
    Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between mianserin, an antidepressant drug, and central H1- and H2-histamine-receptors: in vitro and in vivo studies and radioreceptor assay.
    Nowak JZ; Arrang JM; Schwartz JC; Garbarg M
    Neuropharmacology; 1983 Mar; 22(3):259-66. PubMed ID: 6302549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential photoaffinity labelling of serotonin-S2 receptors and histamine-H1 receptors using 7-azidoketanserin.
    Wouters W; Van Dun J; Leysen JE; Laduron PM
    FEBS Lett; 1985 Mar; 182(2):291-6. PubMed ID: 3979551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM; Janssen PF; Gommeren W; Leysen JE
    Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of binedaline, a new antidepressant drug.
    Morin D; Zini R; Urien S; Tillement JP
    J Pharmacol Exp Ther; 1989 Apr; 249(1):288-96. PubMed ID: 2540319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H1 receptors in human brain labelled with [3H]doxepin.
    Kanba S; Richelson E
    Brain Res; 1984 Jun; 304(1):1-7. PubMed ID: 6146381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Mianserin binding to solubilized membranes of frontal cortex.
    Chan B; Madras BK
    Eur J Pharmacol; 1982 Sep; 83(1-2):1-10. PubMed ID: 7128693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide hydrolysis mediated by histamine H1-receptors in rat brain cortex.
    Claro E; Arbonés L; García A; Picatoste F
    Eur J Pharmacol; 1986 Apr; 123(2):187-96. PubMed ID: 3011460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.